Antimicrobial Viewpoints

About
Experts
Webinars & Conferences
Antimicrobial Viewpoints
Resources
- Library
- Antimicrobial Encyclopaedia
JOIN US
My account
- Logout

You are here:Home-Antimicrobial Viewpoints

<br>The antibiotic R&D landscape in Japan</br><em> – by Norio Ohmagari</em> — The antibiotic R&D landscape in Japan – by Norio Ohmagari
25 November 2020

<br>Tackling the drug-resistance pandemic – 2020 and beyond</br><em> – by Laura J.V. Piddock</em> — Tackling the drug-resistance pandemic – 2020 and beyond – by Laura J.V. Piddock
23 November 2020

<br>Why are new antibacterials failing as commercial products?</br><em> – by Patricia A. Bradford</em> — Why are new antibacterials failing as commercial products? – by Patricia A. Bradford
19 November 2020

<br>COVID-19: Coinfection, secondary bacterial infections and AMR in India</br><em> – by Venkatasubramanian Ramasubramanian</em> — COVID-19: Coinfection, secondary bacterial infections and AMR in India – by Venkatasubramanian Ramasubramanian
12 November 2020

<br>Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic</br><em> – by Markus Heep, Esther Bettiol, Tanyaporn Wansom and Hilary Johnstone </em> — Running a phase 3 trial for a new drug for gonorrhoea during the coronavirus pandemic – by Markus Heep, Esther Bettiol, Tanyaporn Wansom ...
15 October 2020

<br>A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need</br><em> – by John Rex</em> — A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need ...
6 October 2020

<br>Why we need a new access model for antibiotics</br><em> – by Yann Ferrisse and Fernando Pascual Martinez</em> — Why we need a new access model for antibiotics – by Yann Ferrisse and Fernando Pascual Martinez
1 October 2020

<br>Moving from paper to action – The status of National AMR Action Plans in African countries</br><em> – by Mirfin Mpundu</em> — Moving from paper to action – The status of National AMR Action Plans in African countries – by Mirfin Mpundu
25 September 2020

<br>Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them</br><em> – by Jack Stone and Maria Laura Ciusa</em> — Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them – by Jack Stone and Maria Laura ...
5 August 2020

<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em> — Getting the most out of antimicrobial surveillance – by Mariana Castanheira
28 May 2020

<br>COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?</br><em> – by Stephan Harbarth</em> — COVID-19 and antimicrobial resistance: Are there any unknowns that will become known? – by Stephan Harbarth
13 May 2020

<br>COVID-19 and its impact on antimicrobial stewardship</br><em> – by Andrew Seaton</em> — COVID-19 and its impact on antimicrobial stewardship – by Andrew Seaton
30 April 2020

1
2
3
Next »

Share

Facebook Twitter LinkedIn Reddit Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

Antimicrobial Viewpoints (32)
Conferences (17)
Experts (100)
External webinars (19)
Uncategorized (2)
Webinars (35)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy